Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Jun 11;55(6):2001148.
doi: 10.1183/13993003.01148-2020. Print 2020 Jun.

Arterial hypertension and the risk of severity and mortality of COVID-19

Carlos Enrique Leiva Sisnieguez  1 , Walter Gastón Espeche  2 , Martín Rogelio Salazar  2
Affiliations
Comment

Arterial hypertension and the risk of severity and mortality of COVID-19

Carlos Enrique Leiva Sisnieguez et al. Eur Respir J. .

Abstract

Arterial hypertension implies the risk of a hard COVID-19 outcome. This may be explained by potential confounding factors, such as age and cardiovascular disease. https://bit.ly/2Kr6Ax4

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: C.E. Leiva Sisnieguez has nothing to disclose. Conflict of interest: W.G. Espeche has nothing to disclose. Conflict of interest: M.R. Salazar has nothing to disclose.

Comment on

  • Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis.
    Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, Liu XQ, Chen RC, Tang CL, Wang T, Ou CQ, Li L, Chen PY, Sang L, Wang W, Li JF, Li CC, Ou LM, Cheng B, Xiong S, Ni ZY, Xiang J, Hu Y, Liu L, Shan H, Lei CL, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Cheng LL, Ye F, Li SY, Zheng JP, Zhang NF, Zhong NS, He JX; China Medical Treatment Expert Group for COVID-19. Guan WJ, et al. Eur Respir J. 2020 May 14;55(5):2000547. doi: 10.1183/13993003.00547-2020. Print 2020 May. Eur Respir J. 2020. PMID: 32217650 Free PMC article.

References

    1. Guan W-J, Liang W-H, Zhao Y, et al. . Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J 2020, 55: 2000547. - PMC - PubMed
    1. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020; 13: 1239–1242. - PubMed
    1. Guan WJ, Ni ZY, Hu Y, et al. . Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382: 1708–1720. - PMC - PubMed
    1. Ruan Q, Yang K, Wang W, et al. . Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med 2020; 46: 846–848. - PMC - PubMed
    1. Yang J, Zheng Y, Gou X, et al. . Prevalence of comorbidities and its effects in coronavirus disease 2019 patients: a systematic review and meta-analysis. Int J Infect Dis 2020; 94: 91–95. 10.1016/j.ijid.2020.03.017. - DOI - PMC - PubMed